Hartford HealthCare was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance. Leaders of the two institutions gathered in Hartford to mark the establishment of the alliance during a press conference, and local TV news affiliates were there to capture the story.
In September 2013, we announced the selection of Hartford HealthCare (HHC), a multihospital healthcare system in Connecticut, as the pioneering member in the Memorial Sloan Kettering Cancer Alliance. Among the many distinctive aspects of the collaboration will be the establishment of the first Memorial Sloan Kettering Cancer Alliance clinical trials site.
At present, physicians and leadership from Memorial Sloan Kettering are working together to optimize and enhance HHC’s programs of cancer care and clinical research. In addition, we are jointly recruiting a Chief Medical Officer of the Hartford Healthcare Cancer Institute who will be on the staff at both HHC and Memorial Sloan Kettering.
As the partnership moves forward, certain HHC Cancer Institute oncologists will be integrated into our disease management teams and have the opportunity to make on-site observations of new techniques, bringing the knowledge they acquire back to their colleagues in the HHC system. Both institutions will share educational resources, and will conduct joint quality and outcomes research in order to measure the success of our partnership. HHC will be empowered to continue learning, adapting to, and adopting Memorial Sloan Kettering’s standards of care within the context of its own institution and in the context of the communities it serves.
You can read the frequently asked questions for more information about the alliance.